Trademarkia Logo

Canada

C$
Trademark Search in Canada
PHARMA MSH

View On IC.GC.CA

PHARMA MSH
SEARCHED

on 3 Jan 2025

Last Applicant/ Owned by

Endoceutics Pharma (MSH) inc.

2795 Boulevard Laurier, suite 500Québec

QUEBEC

CA

G1V4M7

Serial Number

2136050 filed on 27th Sept 2021

Correspondent Address

FASKEN MARTINEAU DUMOULIN S.E.N.C.R.L., SRL

365, rue Abraham-Martinbureau 600Québec

QUEBEC

CA

G1K8N2

PHARMA MSH

Trademark usage description

full line of pharmaceutical products, namely analgesics, antihistamines, anti-inflammatories, antibiotics, antifungals, antipsychotics, anti-parkinson Read More

Classification Information

Class [005]
Full line of pharmaceutical products, namely analgesics, antihistamines, anti-inflammatories, antibiotics, antifungals, antipsychotics, anti-parkinsonian agents, laxatives, neuroleptics, anti-tuberculosis agents, stool softeners, dental rinses, cough syrups, enemas, antiseptics, germicides, allergy medications; pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for the treatment of infections, diseases and disorders of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for use in dermatology namely for the treatment of dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for the treatment of metabolic diseases and disorders namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system namely growth and thyroid disorders; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations for the treatment of infectious diseases namely respiratory infections, eye infections; pharmaceutical preparations for use in oncology; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical products for ophthalmological use; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for use in the treatment of inflammatory diseases; pharmaceuticals for the treatment of infectious diseases; pharmaceuticals for the treatment of viral diseases; pharmaceuticals for treating respiratory diseases; vitamins and vitamin preparations; natural health products for the treatment of allergies, chronic pain, fever, inflammatory muscle diseases and disorders, colds and flu, sore throat and cough, diarrhea, nausea, occasional constipation, rehydration, dry nose, urinary tract infection, for the relief of pain, antibiotic creams and ointments, hemorrhoid preparations, dietary supplements for general health and well-being, herbal supplements for general health and well-being, nutritional supplements for general health and well-being.

Classification kind code

11

Class [040]
Custom manufacture of pharmaceutical products, veterinary and sanitary preparations and medical supplies, nutritional supplements and natural health products to the order and specification of others.

Classification kind code

11

Class [042]
Advisory services in the field of patient care, medication, health, pharmaceutical, medical and clinical related questions and issues.

Classification kind code

11

Class [044]
Medical and veterinary, beauty, agricultural and forestry

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

2136050

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 3rd Jan 2025		Search Recorded
Submitted for opposition 20
on 3rd Jan 2025		Examiner's First Report
Submitted for opposition 287
on 27th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 287
on 26th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 27th Sept 2021		Filed
Submitted for opposition 1
on 27th Sept 2021		Created
Submitted for opposition 31
on 27th Sept 2021		Formalized